December 23, 2008
BD to Present at Investor Healthcare Conferences
|
December 15, 2008
BD Biosciences Launches BD™ Human Pluripotent Stem Cell Sorting and Analysis Kit
|
December 04, 2008
BD Receives FDA Approval for the BD FocalPoint™ GS Imaging System to Enhance the Detection of Cervical Cancer
|
December 01, 2008
BD Launches 8mm BD AutoShield™ Pen Needle
|
November 25, 2008
BD Board Declares Dividend Increase and Authorizes Additional Share Repurchases
|
November 25, 2008
BD Biosciences Announces Availability of New CD4 Technology in Africa
|
November 21, 2008
BD Increases Production Capacity for BD SafetyGlide™ Needles and Other Safety-Engineered Injection Devices
|
November 20, 2008
BD Announces Health Canada Licensing of Novel Molecular Assay for Detection of Clostridium difficile Toxin B Gene
|
November 08, 2008
BD Launches BD Atomic Edge™ Safety LRI Knives
|
November 05, 2008
BD Announces Results for Fourth Fiscal Quarter and Full Year
|
November 05, 2008
BD Announces Executive Appointments of President and Chief Financial Officer
|
November 03, 2008
BD to Present at Investor Healthcare Conferences
|
October 22, 2008
Collaborative Partnership Formed to Improve the Health of Health Care Workers
|
October 13, 2008
United Nations Secretary-General Statement Regarding HIV/AIDS (PDF)
|
October 03, 2008
BD Sponsors Campaign to Raise Awareness of XDR-TB (Extensively Drug-Resistant Tuberculosis)
|
October 02, 2008
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
|
October 02, 2008
BD Biosciences to Open New Animal-Free, Antibiotic-Free Cell Culture Media Manufacturing Facility
|
September 30, 2008
BD Breaks Ground on Major Manufacturing Facility in Tatabánya
|
September 25, 2008
Clinton Global Initiative Announces BD's Commitment To Biamba Marie Mutombo Hospital
|
September 23, 2008
Luminex and BD Sign Agreement to Create Diagnostic Tests for Cancer
|
September 10, 2008
BD Celebrates Opening of New Automated Warehouse in Fraga
|
July 24, 2008
BD Announces Results for Third Fiscal Quarter
|
July 22, 2008
BD Board Declares Dividend
|
July 07, 2008
BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections
|
June 25, 2008
BD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
|
June 12, 2008
BD Biosciences and San Jose Mayor Celebrate Opening of State-of-the-Art Office Space and Customer Training Center
|
June 10, 2008
BD Celebrates Opening of New Manufacturing Center in Québec
|
June 04, 2008
BD Biosciences Earns Prestigious Life Science Industry Award for Best Flow Cytometry-based Cell Biology Instruments
|
June 03, 2008
BD to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
|
June 02, 2008
New BD BACTEC™ FX Blood Culture Instrument with the BD EpiCenter™ Operating System can Facilitate Fast and Effective Clinical Decisions for Patients with Bacterial Infections
|
May 23, 2008
BD Biosciences Launches BD AttoVision™ Software v1.6
|
May 20, 2008
BD Board Declares Dividend
|
May 13, 2008
BD Announces Acquisition of Cytopeia
|
May 07, 2008
BD to Present at Investor Healthcare Conferences
|
May 01, 2008
BD Announces CE Marking of the BD GeneOhm™ VanR Molecular Test for the Rapid Detection of Vancomycin Resistance
|
May 01, 2008
BD Biosciences Announces Agreement with 3-D Matrix to Market BD™ PuraMatrix™ Peptide Hydrogel Products to the Research Community
|
April 23, 2008
BD Announces Results for Second Fiscal Quarter
|
April 08, 2008
BD Opens New Manufacturing Facility in Suzhou, China to Produce Rapid Diagnostic Products
|
April 04, 2008
BD Biosciences Announces Winners of 2007 Research Grant Program
|
April 03, 2008
BD Biosciences Launches New BD™ High-Performance Calcium Dye Assay Kit
|
March 27, 2008
BD and Direct Relief International Launch Second Volunteer Service Trip to Improve Healthcare in Ghana
|
March 26, 2008
BD Venflon™ Pro Safety Catheter Wins Award in Prestigious International Design Competition
|
March 26, 2008
BD to Present at the Leerink Swann Molecular Diagnostics Roundtable Conference
|
March 26, 2008
BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
|
March 18, 2008
BD Board of Directors Elects John R. Considine as Vice Chairman and Member of the Board of Directors
|
March 17, 2008
BD GeneOhm™ MRSA Assay Part of Largest U.S. Study Using Universal Active Surveillance to Significantly Reduce MRSA Infection Rates
|
February 13, 2008
First European Application Filed for Product Using Innovative Intradermal Microinjection System BD Soluvia™
|
January 29, 2008
BD Board Declares Dividend
|
January 29, 2008
BD Announces Results of Shareholder Votes at Annual Meeting
|
January 28, 2008
BD to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
|
January 24, 2008
BD Announces Results for First Fiscal Quarter
|
January 18, 2008
BD Biosciences Launches New BD FACSAria™ II Cell Sorting System
|
January 16, 2008
BD Announces Webcast of Annual Meeting of Shareholders
|
January 04, 2008
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
|
January 02, 2008
BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures
|
